New Drug Tariff Part VIIIA category, Category H, to be introduced in March 2026.

Source: NHSBSA

Further to the Community Pharmacy Contractual Framework (CPCF) 2025/26 agreement and following
consultation with Community Pharmacy England (CPE), this is advance notice for contractors that a new
Part VIIIA category, Category H, will be introduced in March 2026.

As part of the 2025/26 funding settlement, we set out a range of actions to improve medicine margin
arrangements. This included changing reimbursement price-setting arrangements for products in
Category C where there are multiple source products. Currently, the product reimbursement price
listed in Category C is based on a specific product – often because it is the only brand available.
However, there are some products where there is more than one supplier – these will begin to
move into Category H, where the price will be calculated using information from suppliers obtained
under the Health Service Products (Provision and Disclosure of Information) Regulations 2018.

Products currently listed in Category C, where there is more than one supplier, will move to
Category H in a phased approach.

Click here for the source.